Last $146.25 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bayer ag-reg (BAYZF)

Although debt as a percent of total capital increased at Bayer AG over the last fiscal year to 51.95%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 72.01 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 140.89 days.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Euros
As of:Dec 31
2011
Reclassified
EUR
Dec 31
2012
Restated
EUR
Dec 31
2013
Reclassified
EUR
Dec 31
2014
EUR
4 Year
Trend
Assets    
Cash and Equivalents1,770.01,698.01,662.01,853.0
Short-Term Investments590.0143.0167.0154.0
Trading Asset Securities--196.0----
TOTAL CASH AND SHORT TERM INVESTMENTS2,360.02,037.01,829.02,007.0
Accounts Receivable7,061.07,458.07,569.09,097.0
Notes Receivable1,931.088.038.0177.0
Other Receivables1,785.01,826.01,649.01,803.0
TOTAL RECEIVABLES10,777.09,372.09,256.011,077.0
Inventory6,368.06,991.07,129.08,478.0
Other Current Assets563.0610.0814.0665.0
TOTAL CURRENT ASSETS20,068.019,010.019,028.022,227.0
Gross Property Plant and Equipment27,076.028,025.028,455.031,319.0
Accumulated Depreciation-17,253.0-18,127.0-18,440.0-19,891.0
NET PROPERTY PLANT AND EQUIPMENT9,823.09,898.010,015.011,428.0
Goodwill9,160.09,293.09,862.016,168.0
Long-Term Investments595.0528.0430.0492.0
Accounts Receivable, Long Term35.09.08.08.0
Loans Receivable, Long Term804.0754.0777.0738.0
Deferred Tax Assets, Long Term1,311.01,579.01,596.02,981.0
Deferred Charges, Long Term809.0920.0673.0753.0
Other Intangibles9,516.08,571.08,270.014,924.0
Other Long-Term Assets644.0756.0658.0515.0
TOTAL ASSETS52,765.051,318.051,317.070,234.0
    
LIABILITIES & EQUITY    
Accounts Payable3,779.04,305.04,473.05,363.0
Accrued Expenses815.0782.0782.03,216.0
Current Portion of Long-Term Debt/Capital Lease3,399.02,568.03,441.03,376.0
Current Portion of Capital Lease Obligations53.0235.051.053.0
Current Income Taxes Payable76.072.0101.063.0
Other Current Liabilities, Total5,185.05,247.05,104.03,278.0
Unearned Revenue, Current136.0130.0122.0207.0
TOTAL CURRENT LIABILITIES13,390.013,104.014,023.015,503.0
Long-Term Debt7,249.06,655.05,259.018,096.0
Capital Leases501.0307.0331.0388.0
Minority Interest120.0100.086.0112.0
Unearned Revenue, Non-Current253.0216.0197.0929.0
Pension & Other Post-Retirement Benefits7,870.09,246.07,368.012,236.0
Deferred Tax Liability Non-Current2,116.0935.01,193.0689.0
Other Non-Current Liabilities2,054.02,304.02,142.02,175.0
TOTAL LIABILITIES33,433.032,767.030,513.050,016.0
Common Stock2,117.02,117.02,117.02,117.0
Retained Earnings12,755.011,861.014,817.012,974.0
Comprehensive Income and Other4,340.04,473.03,784.05,015.0
TOTAL COMMON EQUITY19,212.018,451.020,718.020,106.0
TOTAL EQUITY19,332.018,551.020,804.020,218.0
TOTAL LIABILITIES AND EQUITY52,765.051,318.051,317.070,234.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYZF:US $146.25 USD 0.00

BAYZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $56.86 USD 0.00
Celgene Corp $120.71 USD 0.00
Gilead Sciences Inc $103.42 USD 0.00
SABMiller PLC 3,731 GBp -37.50
Sanofi €87.62 EUR -0.22
View Industry Companies
 

Industry Analysis

BAYZF

Industry Average

Valuation BAYZF Industry Range
Price/Earnings 29.3x
Price/Sales 2.4x
Price/Book 5.0x
Price/Cash Flow 29.3x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.